Health insurance reforms and loss ratio laws

Mark Cuban is right to ask why an insurer will happily pay $2,500 for an MRI when a high‑quality center down the street charges a fraction of that. As a practicing orthopedic surgeon, I'm convinced the real problem isn't clinical; it's structural. The Affordable Care Act’s Medical Loss Ratio (MLR) rule sounds consumer‑friendly, but it actually rewards insurers for higher medical spending, not smarter medical spending. If an insurer lowers costs too effectively, its “medical loss” shrinks and it risks falling out of compliance or owing rebates. Therefore, there is little incentive to steer patients to the $350 MRI instead of the $2,500 one. · MLR ties insurer margins to their spending, so bigger bills can translate into bigger absolute profits as long as the percentage stays within the 80–85% band. · That dynamic empowers layers of middlemen—PBMs, large hospital systems, and vertically integrated insurers—who benefit from opacity and “allowed” prices that make no sense to patients or frontline clinicians. For patients, this manifests as higher premiums, steeper deductibles, and delayed care, not better outcomes. When a simple orthopedic MRI is billed at 8–10 times its cash cost, employers and families pay the difference over time, even if “insurance covered it.” Years ago, a walk‑in orthopedic model like OrthoNOW® was built precisely to deliver timely, specialized musculoskeletal care and avoid unnecessary ER visits and excess imaging charges. Yet the prevailing incentive structure cemented by MLR and controlled by powerful intermediaries has largely ignored these cost‑effective innovations, because they reduce the very spending that drives insurer revenue. If policymakers are serious about affordability, MLR must be reformed to reward value: appropriate diagnostics, site‑of‑care efficiency, and real price transparency. Until incentives align with outcomes, frontline physicians and patients will keep asking the same question Mark Cuban did: Why are we paying Cadillac prices for services that clearly come with a Honda‑level cost? #Healthcare #HealthCareReform #HealthPolicy #MedicalCosts #MRIPricing #PriceTransparency #ValueBasedCare #PatientFirst #DrBadia #MarkCuban #HealthEquity #FixHealthcare #HealthcareInnovation #InsuranceReform

6 of 7 major health insurers paid out more in medical claims from 2021-2025. They cut administrative staff to offset the costs. Providers absorbed that burden. Medical loss ratio (MLR) measures how much of every premium dollar goes to actual medical care. An MLR of 90% means 90 cents goes to care, 10 cents to everything else: salaries, buildings, technology, profit. From 2021-2025, 6 of 7 major insurers saw rising MLR trends. CVS/Aetna: +6.8 points. Biggest jump (86.0% → 92.8%). 1,000+ employees laid off since October 2023. 30% of prior authorizations automated by 2024. $20B investment in AI and digital systems. Margin compression = aggressive cost cuts. UnitedHealth: +6.5 points. 82.6% → 89.1%. Billions quarterly on AI and automation. Late 2025 deployment of AI-powered prior authorization tools. Largest insurer, largest absolute margin squeeze. Elevance Health: +5.8 points. 87.7% → 93.5%. Highest MLR in the industry. Keeps only 6.5% of premiums. Blue Cross/Blue Shield plans. Provider appeals volume up 140%. Humana: +4.0 points. 87.1% → 91.1%. Medicare Advantage-focused. Margin compression from older, higher-cost patients. Centene: +4.9 points. 87.8% → 92.7%. Medicaid-heavy. Revenue grew 41.5% to $167B but MLR climbed faster. Molina: +4.5 points. 86.8% → 91.3%. Medicaid specialist. Revenue grew 65.8% to $44.6B. Strong growth but rising MLR. Cigna: -1.9 points. Only decrease. 86.7% → 84.8%. Keeps 15.2% of premiums: more than double Elevance. $200M+ quarterly on digital health. Early automation = margin protection while others scrambled. Provider impact: Industry administrative costs hit $67.4B annually in 2025, up 6.2%. Prior authorization volume per physician grew from 39 requests weekly (2021) to 43 requests (2024). Processing averaged 3-14 days in 2021. From 2021-2025, all major carriers deployed widespread automation. CVS cut 1,000+ administrative jobs while automating 30% of prior authorizations. Same pattern across all seven: MLR pressure → staff cuts + automation → provider burden increased. 28.7% of Medicare Advantage denials get reversed on appeal. External appeals: 64-83%. When most denials get reversed, it means the initial denial shouldn't have happened. Automated systems flag more cases, but fewer staff are available to review them. Prior authorization burden falls heaviest on radiology and imaging. High authorization exposure, declining reimbursement, 3-4 week approval delays. Each authorization costs providers $11-20 in administrative expenses. Some imaging centers dedicate full-time staff just to managing prior auth queues.

UnitedHealth might be gaming medical loss ratio rules. A new study suggests they're shifting administrative spending to medical spending by paying their 90,000 employed physicians higher salaries. On paper, it looks like they're spending more on care. But they're just reclassifying overhead. The MLR rule requires insurers to spend at least 80% of premiums on medical care. It's designed to prevent insurers from pocketing premiums while skimping on coverage. But when the same company owns both the insurance plan and the physician group, the line between "medical" and "administrative" spending gets blurry. Pay a Optum physician $300,000 instead of $250,000? That extra $50,000 counts as medical spending, even if it's really covering administrative overhead that used to sit on the insurance side of the business. UnitedHealth denies the allegations. But the incentive structure is obvious. Vertical integration creates opportunities to shuffle money between buckets in ways that look good for regulatory compliance but don't actually change how much care patients receive. If payers can game MLR through vertical integration, the rule stops protecting patients and just becomes another accounting exercise. The MLR was built to ensure premium dollars fund care, not profit. If the biggest insurer in America can restructure around it, the rule needs fixing, right? 💌 Read more on the MLR: [https://lnkd.in/ef7SMPvy]

Yesterday’s Energy & Commerce hearing with insurer CEOs confirmed something many of us know—and that Chairman Guthrie forced to be acknowledged on the record: Premiums are rising because healthcare costs are rising. Subsidies don’t change that. They just soften the landing. Medical Loss Ratio (MLR) rules cap margins as a percentage of premium—but they don’t cap dollars. So when costs go up, premiums go up. And when premiums go up, absolute dollars increase—even if margins stay “controlled.” That’s not a surprise. That’s an incentive structure. And when profit is constrained in one part of the system, capital doesn’t disappear—it moves. That’s how we ended up with massive vertical integration across insurance, PBMs, providers, and data—most visibly with companies like UnitedHealth Group. The CEOs defended coordination, scale, and experience—and some truly have lost money in the exchanges. Both things can be true. Intentions aside, outcomes are what matter—and today’s outcomes are predictable by design. We regulate spending ratios, not cost containment. We measure compliance, not total system value. We cap margins in one lane and then wonder why profits shift to another. If we want affordability: • We have to address root cost drivers (hospital pricing, site of care, PBMs, utilization). • We have to reward actual cost reduction, not higher spending with better optics. • And we have to be honest: subsidies are relief—not reform. Necessary today, but insufficient on their own. If we don’t fix the wound, we’ll keep relying on bandages. Brokers, employers, policymakers—we all operate inside this system. The real question isn’t who to blame. It’s what we choose to incentivize next—and who we’re willing to hold accountable for the outcomes. Let’s not continue to normalize dysfunction. #HealthcareAffordability #HealthPolicy #IncentivesMatter #CostContainment #MLR #EmployerSponsoredHealthcare #VelvetHammer

Jeff Immelt once told me that he thought, from his experience as CEO of GE, that one of the huge problems with health care in the U.S. was the consolidation. This article does two things that ought to be of interest to people interested in why health care in the U.S. is so expensive: 1) it reports on the concentration of health benefits administrators (which is, as Immelt thought, high), and 2) it raises the issue of problems with vertical integration. Health insurers were, by law, required to pay out 85% (or 80%, depending on various factors) of premiums collected in either medical benefits or documented efforts to improve performance. BUT, it turns out the easiest, and most profitable, way to meet the medical loss ratio payout numbers is simply to, if an entity owns providers, have the providers increase their prices. Which is precisely what is happening. This is yet another example of how the failure to pursue a vigorous antitrust policy, which should be of interest to conservatives who believe in markets and liberals who believe in lower prices, has left our health system unduly concentrated, overly expensive, and ripe for self-dealing. #healthinsurance #healthcare #concentration #prices #selfdealing https://lnkd.in/eBwefgiE

United and other big carriers now own doctors, clinics, and hospitals, and experts say this creates a dangerous loophole in the MLR rules. “Insurers that own medical clinics may be able to use these relationships to game medical loss ratio requirements. There is no MLR requirement for providers. This creates an incentive for the insurer to direct spending to these affiliated provider entities, which may charge inflated prices, allowing the insurer to increase its reported MLR without delivering more care or improving quality.” We are already seeing it- -A Stat report in 24 found that UnitedHealth pays its own Optum physicians more than others in the same markets. -A WSJ story in 23 revealed that insurers and PBMs overcharge for generics when purchased within their own networks. One more trick in a very long playbook of overcharging. https://lnkd.in/gfX6_MCK